Our study assessed the medium‐term functional impact on COVID‐19‐IS patients and found a nearly significant worse 3‐month outcome after propensity score matching for prognostic baseline features and acute revascularization treatment (Figure 2 ).
← all excerpts
Ischemic stroke in COVID-19 patients: Mechanisms, treatment, and outcomes in a consecutive Swiss Stroke Registry analysis.
1
—
—